These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35140225)

  • 21. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase.
    Holt ME; Mittendorf KF; LeNoue-Newton M; Jain NM; Anderson I; Lovly CM; Osterman T; Micheel C; Levy M
    JCO Clin Cancer Inform; 2021 Sep; 5():995-1004. PubMed ID: 34554823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.
    Doig KD; Fellowes A; Bell AH; Seleznev A; Ma D; Ellul J; Li J; Doyle MA; Thompson ER; Kumar A; Lara L; Vedururu R; Reid G; Conway T; Papenfuss AT; Fox SB
    Genome Med; 2017 Apr; 9(1):38. PubMed ID: 28438193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
    Horak P; Leichsenring J; Goldschmid H; Kreutzfeldt S; Kazdal D; Teleanu V; Endris V; Gieldon L; Allgäuer M; Volckmar AL; Dikow N; Renner M; Kirchner M; Penzel R; Ploeger C; Brandt R; Seker-Cin H; Budczies J; Heilig CE; Neumann O; Schaaf CP; Schirmacher P; Fröhling S; Stenzinger A
    Genes Chromosomes Cancer; 2022 Jun; 61(6):303-313. PubMed ID: 34331337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.
    Rusch M; Nakitandwe J; Shurtleff S; Newman S; Zhang Z; Edmonson MN; Parker M; Jiao Y; Ma X; Liu Y; Gu J; Walsh MF; Becksfort J; Thrasher A; Li Y; McMurry J; Hedlund E; Patel A; Easton J; Yergeau D; Vadodaria B; Tatevossian RG; Raimondi S; Hedges D; Chen X; Hagiwara K; McGee R; Robinson GW; Klco JM; Gruber TA; Ellison DW; Downing JR; Zhang J
    Nat Commun; 2018 Sep; 9(1):3962. PubMed ID: 30262806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
    Tao JJ; Schram AM; Hyman DM
    Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
    Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
    Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
    Dienstmann R; Jang IS; Bot B; Friend S; Guinney J
    Cancer Discov; 2015 Feb; 5(2):118-23. PubMed ID: 25656898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
    Cooper LA; Demicco EG; Saltz JH; Powell RT; Rao A; Lazar AJ
    J Pathol; 2018 Apr; 244(5):512-524. PubMed ID: 29288495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the OncoGenomic Landscape of cancer.
    Mateo L; Guitart-Pla O; Duran-Frigola M; Aloy P
    Genome Med; 2018 Aug; 10(1):61. PubMed ID: 30071882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
    Patel NM; Michelini VV; Snell JM; Balu S; Hoyle AP; Parker JS; Hayward MC; Eberhard DA; Salazar AH; McNeillie P; Xu J; Huettner CS; Koyama T; Utro F; Rhrissorrakrai K; Norel R; Bilal E; Royyuru A; Parida L; Earp HS; Grilley-Olson JE; Hayes DN; Harvey SJ; Sharpless NE; Kim WY
    Oncologist; 2018 Feb; 23(2):179-185. PubMed ID: 29158372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
    Kim H; Lee AJ; Lee J; Chun H; Ju YS; Hong D
    Genome Med; 2019 Dec; 11(1):81. PubMed ID: 31847917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors.
    Conroy JM; Pabla S; Glenn ST; Seager RJ; Van Roey E; Gao S; Burgher B; Andreas J; Giamo V; Mallon M; Lee YH; DePietro P; Nesline M; Wang Y; Lenzo FL; Klein R; Zhang S
    PLoS One; 2021; 16(12):e0260089. PubMed ID: 34855780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current state of clinical interpretation of sequence variants.
    Hoskinson DC; Dubuc AM; Mason-Suares H
    Curr Opin Genet Dev; 2017 Feb; 42():33-39. PubMed ID: 28157586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Artificial intelligence-guided precision medicine in hematological disorders].
    Yokoyama K
    Rinsho Ketsueki; 2020; 61(5):554-563. PubMed ID: 32507824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RDF SKETCH MAPS - KNOWLEDGE COMPLEXITY REDUCTION FOR PRECISION MEDICINE ANALYTICS.
    Thanintorn N; Wang J; Ersoy I; Al-Taie Z; Jiang Y; Wang D; Verma M; Joshi T; Hammer R; Xu D; Shin D
    Pac Symp Biocomput; 2016; 21():417-28. PubMed ID: 26776205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POKR: Building a Computable Heterogeneous Knowledge Resource for Precision Oncology.
    Guo Y; Wang C; Moore R; Liu H; Shen F
    Stud Health Technol Inform; 2022 Jun; 290():243-247. PubMed ID: 35673010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. arrayMap: a reference resource for genomic copy number imbalances in human malignancies.
    Cai H; Kumar N; Baudis M
    PLoS One; 2012; 7(5):e36944. PubMed ID: 22629346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.